enrolled

MannKind Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for …

The NHS soup and shakes diet is ‘helping thousands’ put their type 2 diabetes into remission, health service chiefs hailed today. Figures show a record 13,000 adults in England were …